Area of research
Hematology · Genetics
Research interest
Research focused on Multiple myeloma and Bortezomib, with related work in microRNA, Multiplex ligation-dependent probe amplification, Fluorescence in situ hybridization. Notable publications include 'Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma', 'MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma', and 'Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma'.
Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single-cell level by QM-FISH
Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study
Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma
MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma
Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma
Detection of recurrent cytogenetic aberrations in multiple myeloma: A comparison between MLPA and iFISH
Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma
Identification of characteristic and prognostic values of chromosome 1p abnormality by multi-gene fluorescence in situ hybridization in multiple myeloma